SBI Securities
RIGL icon

SBI Securities’s Rigel Pharmaceuticals RIGL Stock Holding History

SBI Securities’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64K Sell
42
-196
-82% -$6.04K ﹤0.01% 2625
2026
Q1 		$6.44K Buy
238
+140
+143% +$4.71K ﹤0.01% 1919
2025
Q4 		$4.2K Buy
98
+64
+188% +$2.41K ﹤0.01% 2093
2025
Q3 		$963 Hold
34
– – ﹤0.01% 2702
2025
Q2 		$637 Hold
34
– – ﹤0.01% 2864
2025
Q1 		$612 Sell
34
-135
-80% -$2.74K ﹤0.01% 2784
2024
Q4 		$2.84K Buy
+169
New +$3.24K ﹤0.01% 2151

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's RIGL Position: Q2 2026 in Review

SBI Securities reduced its Rigel Pharmaceuticals (RIGL) stake by 82% in Q2 2026, selling an estimated $6.04K and leaving 42 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

SBI Securities first reported a position in RIGL in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.44K in Q1 2026. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • SBI Securities held 42 shares of Rigel Pharmaceuticals worth $1.64K as of Q2 2026.
  • SBI Securities sold 196 Rigel Pharmaceuticals shares in Q2 2026, an estimated $6.04K.
  • Rigel Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2625 holding.
  • SBI Securities first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Rigel Pharmaceuticals position peaked at $6.44K in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.